The innate immune response is a critical component of host defense against infection. Defensins, one family of antimicrobial peptides, are an evolutionarily conserved class of innate immune effectors with well-described anti-bacterial activity; however, their role in anti-viral immunity is less well understood. The potent neutralization of diverse viruses by alpha-defensins has been described in vitro and in cell culture. Recent studies have also described enhancement of virus infection by alpha-defensins; however, controlled studies to determine whether these peptides impact virus infection and pathogenesis in vivo have not been reported. This proposal will explore the hypothesis that alpha-defensins modulate enteric non-enveloped virus infection and pathogenesis in vivo, using replicating viruses in a natural host. We will determine the spectrum of activity of mouse enteric alpha-defensins against mouse enteric viruses in vitro. Using this information, we will determine whether alpha-defensin expression directly or indirectly impacts enteric virus infection and pathogenesis in vivo. We will also determine whether host Paneth cells respond to virus infection by degranulating and releasing alpha-defensins into the gut. These studies will provide insight into a critical component of the immune system that may be a common first line of defense against many viral pathogens. In addition, a deeper understanding of enteric virus infection will aid in the design of vaccine vectors to elicit mucosal immunity. Finally, these studies will provide validation for continued studies of the antiviral mechanisms of defensins as well as the development of these molecules as therapeutics for adenovirus and other viral pathogens.

Public Health Relevance

These studies will determine whether a part of the immune system is important for viral pathogenesis and gastrointestinal disease. A detailed understanding of how the immune system modulates virus infection may uncover new ways to prevent disease and may guide the design of antiviral drugs and vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI097311-01A1
Application #
8524035
Study Section
Virology - B Study Section (VIRB)
Program Officer
Leitner, Wolfgang W
Project Start
2012-08-16
Project End
2014-07-31
Budget Start
2012-08-16
Budget End
2014-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$298,862
Indirect Cost
$94,497
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Gounder, Anshu P; Myers, Nicolle D; Treuting, Piper M et al. (2016) Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection. PLoS Pathog 12:e1005474
Wilson, S S; Tocchi, A; Holly, M K et al. (2015) A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions. Mucosal Immunol 8:352-61
Tenge, Victoria R; Gounder, Anshu P; Wiens, Mayim E et al. (2014) Delineation of interfaces on human alpha-defensins critical for human adenovirus and human papillomavirus inhibition. PLoS Pathog 10:e1004360
Wiens, Mayim E; Wilson, Sarah S; Lucero, Carissa M et al. (2014) Defensins and viral infection: dispelling common misconceptions. PLoS Pathog 10:e1004186
Wilson, Sarah S; Wiens, Mayim E; Smith, Jason G (2013) Antiviral mechanisms of human defensins. J Mol Biol 425:4965-80